Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves.
about
Orally administered P22 phage tailspike protein reduces salmonella colonization in chickens: prospects of a novel therapy against bacterial infectionsNatural solution to antibiotic resistance: bacteriophages 'The Living Drugs'Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound modelDynamics of success and failure in phage and antibiotic therapy in experimental infectionsBacteriophage remediation of bacterial pathogens in aquaculture: a review of the technologyIsolation and characterization of a new T-even bacteriophage, CEV1, and determination of its potential to reduce Escherichia coli O157:H7 levels in sheepIsolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumanniiThe in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens.Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system.Phage therapy to reduce preprocessing Salmonella infections in market-weight swineEvaluation of Anti-SE Bacteriophage as Feed Additives to Prevent Salmonella enteritidis (SE) in Broiler.Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease controlUsing bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.Phage therapy as an approach to prevent Vibrio anguillarum infections in fish larvae production.Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad modelCharacterization of a T5-like coliphage, SPC35, and differential development of resistance to SPC35 in Salmonella enterica serovar typhimurium and Escherichia coliEvaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7.Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants.Novel bacteriophage therapy for controlling metallo-beta-lactamase producing Pseudomonas aeruginosa infection in catfish.In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages.Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in miceThe use of phage FCL-2 as an alternative to chemotherapy against columnaris disease in aquacultureEfficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15Phage Therapy - Everything Old is New AgainMicroneedle-mediated transdermal bacteriophage delivery.Bacteriophage biocontrol in animals and meat products.Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine.Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in BangladeshComplete Genome Sequences of Two Escherichia coli Phages, vB_EcoM_ ESCO5 and vB_EcoM_ESCO13, Which Are Related to phAPEC8.A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.Phage Therapy in the Era of Synthetic Biology.Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture.Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickensIdentification and Characterization of Dpo42, a Novel Depolymerase Derived from the Escherichia coli Phage vB_EcoM_ECOO78.Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model.Phage Therapy is Effective in Protecting Honeybee Larvae from American Foulbrood Disease.Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli.
P2860
Q21136065-180E8119-2F14-46AD-A6AE-F748FCA64D5DQ24563742-51D4A4B2-2E15-4D06-9C42-C642CB93503EQ24673374-71884710-AC80-4541-94E2-2082E5371216Q24803578-F1ED234B-0306-40EE-9C1D-56FEE4294CB7Q26998710-52F43F18-2FC0-419A-9BEC-5916368C3351Q28390402-C69D75D3-948D-499C-BA98-1D8D111CE158Q28484243-FD1B885E-7366-446B-AED2-0C5DEBF89056Q30988850-EC0D6955-441B-4D68-94BD-B6ED55333BCBQ33509952-CD84F722-7F75-451C-BC5F-0FCBEDF1312BQ33559532-9E049446-58A6-42AA-B95B-786F61DAE994Q33886221-005BAF3E-F084-4A3B-A4F7-C93AEB118F63Q33986903-9B0C4AB5-9873-4BFC-81BC-73925B24D854Q34506458-4C0F5CDF-D448-452C-9B6E-EE96C0D05DE5Q34612392-0536DB0C-34FC-42F5-A20F-410FD55A1565Q34702499-233CCBB7-AB80-40EE-B8B2-42F80E21D4ADQ34738634-4931E63B-3154-490D-BFBE-60D8FFD30F36Q34777447-5D15C9A6-109F-4DED-8AAD-5BA4D3CB5641Q34973928-63146C34-68E9-488F-9EEE-46E60738D982Q35076244-9E9B7D75-10CD-4E67-A2BC-E8ABDABF36BEQ35124495-15F64CFE-7032-44E1-A990-C6D75DF562C1Q35210425-8E7DBDCD-8E7B-4728-9A0D-6498B03E5005Q35635891-EE06EAB8-6593-4291-BE65-4EF8A515C76DQ35970100-880854E2-7AFC-4A2A-A4EB-8AC5E1CA714FQ36086395-92D7D5E2-BEB0-4F6A-84F8-A4E8246177B5Q36171271-A97956E5-4B38-41BA-A494-120B3E4D63D1Q37187438-1E71251C-ABDA-4268-8EB9-CA5703AD0E35Q37273445-06DF5395-D142-4B37-8B5C-7222DF712603Q37389925-C1DC0185-CB3B-4D56-8B93-D2E127189132Q37504784-55655902-3698-4FE4-87E1-5FD94A15C6F3Q37663297-221E0DB6-BA07-4F63-ABC2-61DDD27E7104Q37731100-7060FB3C-E230-4611-944B-BB58BD0FAB76Q38131268-4E133700-3133-46BC-825F-934E42387925Q38915649-BFF12D23-197C-461C-872F-A0B4C844D0D2Q39023156-ADCDB131-F2CC-47A8-9283-C5BEC0843823Q39742861-D129B469-3B24-4469-95C3-6FBBB55DB4E3Q39799157-FFC74E0D-C32B-40CD-B4FE-2454F5C5BC86Q40086431-03593998-CDF2-4513-837F-B14320C7793CQ41092030-65698B71-3797-47CD-8156-63B9988D82D2Q41127154-FD930E6E-68B6-4043-9BE6-E3CA80D83186Q41361241-D3D900F9-AADD-484A-A180-8E6D87216529
P2860
Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Use of lytic bacteriophage for ...... ngitis in chickens and calves.
@en
Use of lytic bacteriophage for ...... ngitis in chickens and calves.
@nl
type
label
Use of lytic bacteriophage for ...... ngitis in chickens and calves.
@en
Use of lytic bacteriophage for ...... ngitis in chickens and calves.
@nl
prefLabel
Use of lytic bacteriophage for ...... ngitis in chickens and calves.
@en
Use of lytic bacteriophage for ...... ngitis in chickens and calves.
@nl
P2093
P2860
P921
P1476
Use of lytic bacteriophage for ...... ingitis in chickens and calves
@en
P2093
P2860
P304
P577
1998-05-01T00:00:00Z